Newly Approved Drug Therapies (577): Accolate, AstraZeneca

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Accolate

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: AstraZeneca
Approval Status: Approved September 1999
Treatment for: Asthma in pediatric patients

General Information

For the use of Accolate 10 mg oral Tablets for the prophylaxis and chronic treatment of asthma in pediatric patients 7 - 11 years of age.

Mechanism of Action

Tablet

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]